Table 1. Patient's characteristics (n=101).

Characteristics		Value
Age (yr)		46.0 (23–73)
Body mass index		23.0 (17.5–31.6)
Parity		2.0 (0–5)
Menopause
	Yes	34 (33.7)
	No	67 (66.3)
Clinical stage
	IB1	74 (73.3)
	IB2	23 (22.8)
	IIA	4 (3.9)
Histology
	Squamous	75 (74.3)
	Adenocarcinoma	15 (14.9)
	Adenosquamous	6 (5.9)
	Others	5 (4.9)
Pathologic large tumor diameter (cm)		4.0 (1–8)
No. of retrieved pelvic LN		55.0 (16–101)
No. of pelvic LN metastasis		2.0 (1–33)
No. of patients undergoing pelvic and paraaortic lymph dissection		50
No. of retrieved PALN		10.0 (2–30)
No. of PALN metastasis		2.0 (1–17)
Safety margin of vagina (cm)		1.5 (0.4–4.5)
CT regimen
	Single platinum	47 (47)
	Paclitaxel and platinum	54 (53)
Cycles of CT
	3 cycles	31 (31)
	6 cycles	70 (69)

Values are presented as median (range) or number of patients (%).

CT, chemotherapy; LN, lymph node; PALN, paraaortic lymph node.